Examples of using Fixed combination in English and their translations into German
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Ecclesiastic
-
Political
-
Computer
-
Programming
-
Official/political
-
Political
Generics Line extensions Fixed combination OTC Herbal Others.
This fixed combination replaces the three components(abacavir, lamivudine and zidovudine) used separately in similar dosages.
When clinically appropriate, direct change from monotherapy to the fixed combination may be considered.
A cycle includes a fixed combination of different works with 3 to 5 performance dates.
When clinically appropriate, direct change from monotherapy to the fixed combination may be considered.
There are four fixed combinations that allow quick registration changes, Piano, Mezzoforte, Forte and Tutti.
In principle the present Notes for Guidance apply to new fixed combinations as well as to entirely new compounds.
It shall nevertheless be possible to include information on the individual substances in the application for a fixed combination.
This fixed combination replaces the three components(abacavir, lamivudine and zidovudine) used separately in similar dosages.
When clinically appropriate direct change from monotherapy to the fixed combinations may be considered.
The four new electric machine sizes have a fixed combination of distance between tie-bars, clamping force and clamping unit size.
A fixed combination of latanoprost with a betablocker appears to be less harming than application of the two substances separately.
Individual dose titration with each of the twocomponents may be recommended before changing to the fixed combination.
This fixed combination product should only be used in dogs which require both active substances to be administered concomitantly at this fixed dose.
Substances of this type which dissociate prior to absorption into two or more active components maybe regarded for the application of the above provisions as fixed combinations of these substances rather than as chemical entities.
FORTEKOR PLUS is a fixed combination product which should only be used in dogs which require both active substances to be administered concomitantly at this fixed dose.
Patients receiving aliskiren, amlodipine and hydrochlorothiazide from separate tablets given concurrently at the sametime of the day may be switched to a fixed combination tablet of Rasitrio containing the same component doses.
The choice of this fixed combination should be based not only on potential adherence criteria, but mainly on expected efficacy and risk related to the three nucleoside analogues.
Posology in patients not adequately controlled with aliskiren or hydrochlorothiazide monotherapy Individual dose titration with each of the twocomponents may be recommended before changing to the fixed combination.
As a fixed combination, Atripla should not be administered concomitantly with other medicinal products containing any of the components, efavirenz, emtricitabine or tenofovir disoproxil as fumarate.
This section should cover the following points:a therapeutic justification for the product(especially for fixed combinations and new pharmaceutical forms); b efficacy; c safety, taking account of preclinical pharmacology and toxicology studies.
Several studies have suggested that the most active components are likely to be salidroside(rhodioloside) and tyrosol, with other components being inactive when administered alone,but showing synergistic effects when a fixed combination of rhodioloside, rosavin, rosarin and rosin was used.
In line with several formulations for fenofibrate, the fixed combination is recommended to be taken with food because the bioavailability of fenofibrate is increased when administered with food and the lipid-lowering efficacy of pravastatin is not altered.
In the case of new combinations of known substances which have been investigated in accordance with the provisions of this Directive, pharmacokinetic studies of the fixed combination are not required if it canbe justified that the administration of the active ingredients as a fixed combination does not change their pharmacokinetic properties.
The individual components of a fixed combination may be intended to relieve simultaneously different symptoms of such a disease state,, but it will not beproper to regard each individual symptom as an indication for the fixed combination, since it may also occur in other diseases and for treating this symptom alone the other constituents may be irrelevant.
The submission of data on each individual active substance, in conjunction with the required user safety tests,residues depletion studies and clinical studies on the fixed combination product, may be considered a suitable justification for omitting data on the combination product, based on animal welfare grounds and unnecessary testing on animals, unless there is suspected interaction leading to added toxicity.
Unless there is a special rationale, fixed combinations of drugs used for convulsive disorders are generally undesirable and are unlikely to be acceptable until or unless extensive field experience over some years has indicated that a particular mixture is in fact of value and well tolerated in practice see Notes for Guidance on Fixed Combination Products.
Clinical studies investigating the survival time demonstrated that the fixed combination increased the life expectancy in dogs with congestive heart failure with a 89% reduction in the relative risk of cardiac mortality assessed in dogs treated with spironolactone in combination with benazepril(as the hydrochloride) compared to dogs treated with benazepril(as hydrochloride) alone mortality was classified as death or euthanasia due to heart failure.
For the fixing combinations procedure, see point 3.